Epizyme, Inc.(NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced its participation in …
Allianz Life Insurance Company of North America (Allianz Life®) announced that its annual Driving to Donate Charity Golf Tournament raised more than $185,000, surpassing last year’s record total o …
Biogen Idec Inc. (NASDAQ: BIIB) announced that it will participate in a panel at the Citi 9th Annual Biotech Conference. The webcast will be live on Thursday, September 4, 2014 at 10:00a.m. ET.
OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that David Chaplin, Ph.D., CEO, will present a corporate overview at …
Synageva BioPharma Corp. ("Synageva") (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, announced that Sanj K. Patel, President and Chief Executive …
Biogen Idec (NASDAQ: BIIB) announced that Donald R. Johns, M.D., has joined the company as vice president, leading Biogen Idec’s amyotrophic lateral sclerosis (ALS) Innovation Hub (ALS iHub).
Birt-Hogg-Dubé syndrome (BHD)
A blog dedicated to the bone cancer.
Copyright © 2006-2014 CheckOrphan. All rights reserved.
CheckOrphan is a 501(c)(3) nonprofit organization. Contributions to CheckOrphan in the United States and Switzerland are tax-exempt to the extent provided by law.
Powered by GetReelHealth.com
Copyright © 2005-2014